Skip to content

DexCom DXCM Accounts Receivable

Accounts Receivable at other companies

SOL
SOLSSOLS
$632M+15,700%
Orion Group Holdings logo
Orion Group HoldingsORN
$5.05M-86.0%
NOVA, Inc. logo
NOVA, Inc.NOV
$1.81B-4.7%
Wabash National logo
Wabash NationalWNC
$171.82M-9.4%
Cabot Corporation logo
Cabot CorporationCBT
$657M-11.1%
HES
Hess MidstreamHESM
$149.3M+9.2%

Other financials

Income statement

See full
Revenue$1.3B+13.1%
Gross profit$830.0M+20.5%
Operating income$318.3M+49.7%
Net income$249.1M+38.5%
EPS (diluted)$0.64+42.2%

Balance sheet

See full
Cash & equivalents$1.1B-4.8%
Total debt$103.3M-23.1%
Total equity$2.6B+1.9%
Total assets$6.5B-11.9%

Cash flow

See full
Operating cash flow$525.6M+186%
CapEx$76.6M-12.0%
Free cash flow$449.0M+364%

Valuation

See full
Market cap$28.88B-17.6%
Enterprise value$27.88B-18.0%
P/E28.9×-32.4×
P/S5.8×-2.3×

Profitability

See full
Gross margin62.5%+3.7pp
Operating margin22.9%+6.9pp
Net margin20.1%+6.8pp
FCF margin29.7%+15.8pp

Returns & leverage

See full
Return on equity38.5%+15.7pp
Debt / equity0.0×
Current ratio1.7×+0.2×

Where this comes from

Reported directly by DexCom in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: DexCom’s 8-K, filed July 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DexCom's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DexCom's accounts receivable?
DexCom (DXCM) reported accounts receivable of $1.26B in Q2 2026.
How has DexCom's accounts receivable changed year-over-year?
DexCom's accounts receivable decreased by 6.8% year-over-year, from $1.35B to $1.26B.
What is the long-term trend for DexCom's accounts receivable?
Over 5 years (2020 to 2025), DexCom's accounts receivable has grown at a 23.2% compound annual growth rate (CAGR), from $428.5M to $1.22B.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.